Perelel is the first and only female OB/GYN-founded vitamin company offering clean, targeted nutrition for distinct stages of women's hormonal journeys. In 2018, Victoria Thain Gioia and Alex Taylor, both pregnant, found themselves navigating the wildly unregulated world of prenatals. Their paths to parenthood were marked by confusion, frustration, and loss (Victoria endured four miscarriages and is now pregnant with her fourth child). The realization about how incredibly complex women's bodies are and yet how overly reductive and simple most of the products on the market were, led to a search for superior solutions. The lack of information on what to consume during pregnancy and when to do so - along with a lack of industry regulations, inspired them to introduce a more precise and transparent approach to prenatal vitamins. Still today, the Food and Drug Administration (FDA) does not hold vitamins to the same standards as conventional foods or drugs, so manufacturers are responsible for handling safety testing, labeling, and quality standards themselves. This leaves consumers vulnerable to misinformation, predatory marketing, and a lack of control over their bodies. Launched in 2020 along with Medical Co-Founder Dr. Banafsheh Bayati, the company includes a line of 19 individual skus not including bundles with a focus on targeted nutrition for women at various hormonal life stages including prenatal, postpartum care, and general women's wellness. Each formula is meticulously developed in collaboration with a panel of certified OB/GYNs and multidisciplinary women's health experts, and consciously made to support women through key stages of their hormonal journey. As part of their ongoing Health Initiative Fund, Perelel supports improved research in women's health and more accessible education to fuel bodily empowerment and literacy - and has provided $2.5 million in product donations to underserved communities through its 1:1 giveback initiative.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/01/24 | $6,000,000 | Series A |
Selva Ventures Unilever Ventures Willow Growth | undisclosed |
